Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Bio-Techne Corporation

Bio-Techne Corporation (TECH)

Industry: Biotechnology Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $8.05 — $29.76
Selected (Average) $18.83
Upside to Live -72.57%
Full Range Fair Value
Range (Low - High) $9.27 — $32.28
Selected (Average) $20.44
Upside to Live -70.24%
Live Price $68.67

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
ALKS 31 Alkermes plc 1,786 14.62 14.62 10.11 6.09 12.37 12.29
PTCT 32 PTC Therapeutics, 1,779 6.41 6.41 4.99 4.99 377.43 5.87
300122.SZ 33 Chongqing Zhifei B 1,549 - - - - - -
091990.KQ 34 Celltrion Healthca 1,502 232.86 308.39 53.86 52.12 47.95 54.65
0775.HK 35 CK Life Sciences I 1,397 - - 35.45 41.82 15.30 11.04
031390.KQ 36 Green Cross Cell C 1,378 279.76 399.08 20.44 22.42 57.75 -
005257.KS 37 Green Cross Holdin 1,310 26.18 24.87 21.03 21.50 20.82 44.81
TECH 38 Bio-Techne Corpora 1,217 110.91 139.82 39.63 44.50 43.73 85.58
002252.SZ 39 Shanghai RAAS Bloo 1,129 24.10 21.77 23.00 20.89 25.86 19.60
TLX 40 Telix Pharmaceutic 1,095 82.15 82.15 37.79 37.79 89.16 47.72
BAVA.CO 41 Bavarian Nordic A/ 1,083 7.45 5.64 5.07 4.00 3.52 5.10
ACAD 42 ACADIA Pharmaceuti 1,047 13.86 13.86 29.18 29.18 23.93 14.21
APLS 43 Apellis Pharmaceut 1,016 63.40 63.40 26.64 26.64 2.79 30.93
IONS 44 Ionis Pharmaceutic 967 - - - - - -
ALK-B.CO 45 ALK-Abelló A/S 921 41.00 20.73 24.56 18.21 27.36 18.81
600161.SS 46 Beijing Tiantan Bi 909 28.67 24.82 15.22 13.29 29.77 14.46

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple25.1421.2521.0320.8923.9314.33
Full Range Median Multiple27.4223.3023.0021.5025.8616.63
Industry Multiple68.3782.1423.6423.0056.4623.29
Market Implied Multiple136.90172.5948.6754.6553.71105.11
Company (TECH) Multiple110.91139.8239.6344.5043.7385.58
(*) Net Income / EBITDA / Revenue7862224200203104
Winsorized Enterprise ValueN/AN/A4,7164,1724,8621,488
Full Range Median Enterprise ValueN/AN/A5,1564,2935,2531,727
(-) Net Debt236236236236236236
Winsorized Equity Value1,9601,3144,4803,9364,6261,252
Full Range Median Equity Value2,1381,4414,9214,0575,0181,491
(/) Shares Outstanding155155155155155155
Winsorized Fair Value$12.61$8.45$28.82$25.32$29.76$8.05
Full Range Median Fair Value$13.75$9.27$31.65$26.10$32.28$9.59
Current Price$68.67$68.67$68.67$68.67$68.67$68.67
Upside / Downside-81.64%-87.69%-58.04%-63.13%-56.67%-88.27%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$8.83$5.92$20.17$17.72$20.83$5.64
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy